白云山收到广东药品监督管理局核准签发的《药品生产许可证》

格隆汇
09 Apr

白云山(00874.HK)公告,近日,广州白云山医药集团股份有限公司(以下简称“公司”)全资子公司广州白云山明兴制药有限公司(以下简称“明兴药业”)收到广东省药品监督管理局核准签发的《药品生产许可证》,同意明兴药业新增生产范围和生产线,并通过药品生产质量管理规范符合性检查。同意明兴药业在生产地址“广州市白云区健旭三路99号”生产车间“制造八部”、新增生产范围“冻干粉针剂(抗肿瘤药)”、新增生产线“...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10